This Month's Profile Group: VC-Backed GI Start-Ups See Opportunity In IBS features profiles of Altheus, AltheRx, Ardelyx and Second Genome. Plus these Start-Ups Across Health Care: InfraScan, PlaqueTec, Prosonix and Veracyte.
You may also be interested in...
InfraScan Inc. has developed a handheld device for detecting bleeding in the brain in head trauma patients. Such trauma typically causes blood from ruptured vessels to pool in the skull cavity. The trapped blood compresses the brain and increases intracranial pressure, which leads to brain damage. However by beaming near-infrared light at the brain and then analyzing the light reflected back at the device, the Infrascanner reveals the presence or non-presence of an intracranial hematoma, for triage or follow-up diagnostics.
Cambridge, UK-based PlaqueTec Ltd. is developing a coronary artery blood sampling technology combined with biomarker analysis to map the biological processes associated with the development and rupture of vulnerable plaque. The ambitious young company plans to use this information to detect and monitor plaque biomarkers, and then use these patented data to help identify drug candidates for atherosclerosis.
Although 2020 was the best year ever for Swiss biotech financing activities, no domestic IPOs were launched by the sector. But introducing the SPAC might change that.